When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Challenging homografts as the holy grail for aortic valve endocarditis

Michael Flynn, FRCSI(C/Th), Sherard G. Little, MD, Eugene H

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Form ever follows function

Gilbert H. L. Tang, MD, MSc, Ramin Malekan, MD, Cindy J

It is still mostly about the mitral valve

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Bicuspid aortic valve aortopathy: One size fits all?

Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes David M. Overman, MD The Journal of Thoracic.

Long-term results of aortic valve–sparing operations in patients with Marfan syndrome Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures Tirone.

Michael A. Borger, MD, PhD, Patricia M

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

The aortic valve–sparing operation

Open thoracoabdominal aortic repair for chronic type B dissection

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Nilto Carias de Oliveira, MD, Tirone E

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Valve performance classification in 630 subcoronary Ross patients over 22 years Hans-Hinrich Sievers, MD, Ulrich Stierle, MD, Michael Petersen, MD, Stefan.

Christopher M. Feindel, MD, MSc, Maral Ouzounian, MD, PhD

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

The Ross procedure: Time to reevaluate the guidelines

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

The Ross procedure: Outcomes at 20 years

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Prognosis and “granularity”: Building on staging foundations?

Postimplantation morphologic changes of glutaraldehyde-fixed porcine aortic roots and risk of aneurysm and rupture Tirone E. David, MD, Susan Armstrong,

The Mitroflow aortic valve: A past, present, and future illuminated

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Hans-Joachim Schäfers, MD

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Concomitant replacement of the ascending aorta is free—for some

Innovation in cardiothoracic surgical training

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Another case of underprovision of mitral valve repair surgery: Lessons from the Veterans Affairs health system Anelechi C. Anyanwu, MD, David H. Adams,

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

“The more things change…”: The challenges ahead

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Toward a more rational approach in treating type B aortic dissection

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Valve-sparing aortic root replacement in bicuspid aortic valves: A reasonable option? Diana Aicher, MD, Frank Langer, MD, Anke Kissinger, Henning Lausberg,

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Thanos Sioris, MD, Tirone E

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc The Journal of Thoracic and Cardiovascular Surgery Volume 139, Issue 1, Pages 68-75 (January 2010) DOI: 10.1016/j.jtcvs.2009.09.053 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Survival after the Ross operation compared with that of the population in general matched for age and sex. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 68-75DOI: (10.1016/j.jtcvs.2009.09.053) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from any reoperation, reoperation on the pulmonary autograft, and reoperation or catheter-based pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 68-75DOI: (10.1016/j.jtcvs.2009.09.053) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedom from moderate or severe (≥3+) and greater than mild (>2+) aortic insufficiency. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 68-75DOI: (10.1016/j.jtcvs.2009.09.053) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions